Category: 6. Business

Axon Enterprise (AXON) shares have pulled back about 14% over the past month. This has prompted investors to weigh current valuations against the company’s strong annual growth in both revenue and net income.

See our latest analysis for Axon…

If you’re looking for a multi-bagger, there’s a few things to keep an eye out for. Firstly, we’d want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. Put simply,…

Reinsurance Group of America (RGA) has captured investor interest after publishing its latest study estimating a 3.5% reduction in US mortality by 2045, attributed to widespread adoption of GLP-1 medications. This analysis offers fresh insight…

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing…

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically, we’ll want to notice a trend of growing return on capital employed (ROCE) and alongside that, an expanding base of capital…

Henry Schein (HSIC) just lifted its 2025 sales growth guidance, signaling management’s confidence after reporting stronger sales and net income for the quarter compared to last year. This outlook could prompt a closer look from investors.

Nuvalent (NUVL) has scheduled a webcast to present pivotal data from its Phase 1/2 ALKOVE-1 study. The presentation will focus on an investigational ALK-selective inhibitor for advanced non-small cell lung cancer. This update is drawing…

It takes time, money and fossil fuels to make the electronics that underpin modern life. From the mining of rare earths and metals to processing, manufacture and shipping, the engineering and logistical innovations that make it possible to buy a…

The landscape of biomarker testing in non–small cell lung cancer (NSCLC) is undergoing a significant transformation, moving beyond foundational genomic drivers to embrace a new wave of protein-based and computationally derived markers. This…